Figure 4From: Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment Positive predictive value rates for sustained virological response within the initial 12 weeks during pegylated interferon alpha plus ribavirin treatment, classified by TaqMan and qualitative Amplicor assays.Back to article page